WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY

Weill Medical College of Cornell University delivers advanced biomedical research and academic training services to federal agencies, with deep expertise in preclinical drug development, biomarker identification, and infectious disease clinical trial support. The organization specializes in translational biotechnology research, including efficacy modeling, intermediate endpoint validation, and immune repertoire analysis of patient-derived samples, particularly in oncology and autoimmune conditions such as uveitis and tuberculosis. Their technical capabilities encompass molecular diagnostics, immunophenotyping of peripheral blood mononuclear cells, and the design of preclinical pipelines aligned with FDA and NIH standards for therapeutic candidate advancement. As an academic medical institution, they integrate rigorous scientific methodology with regulatory-grade data generation, distinguishing themselves through peer-reviewed research rigor and access to clinical cohorts for translational validation. The institution maintains a strong, sustained relationship with the Department of Health and Human Services, delivering high-impact research services under programs focused on cancer prevention and infectious disease control. It also supports the Department of Defense through tuition and academic training initiatives, indicating a dual role in both scientific innovation and workforce development for military health systems. Primary activity centers on NAICS 541714 for biotechnology R&D and 611310 for higher education services, positioning the entity as a hybrid research-academic provider in the federal life sciences market. Their work bridges laboratory discovery and applied clinical development, serving as a critical node in the federal biomedical innovation pipeline. As a non-profit academic entity based in New York, NY, Weill Medical College operates under its institutional charter without federal small business certifications. Its geographic footprint is anchored in the New York metropolitan research corridor, leveraging proximity to major biomedical hubs and federal health agencies to deliver high-value, science-driven contract services.